Complaint resolutions: how Oath Peptides addresses quality and transparency concerns.

How does Oath Peptides handle complaints?

Product-quality complaints in the research-peptide category are difficult to resolve reactively. Once a customer receives a vial that they believe is mislabeled, under-purity, or contaminated, the path to resolution requires independent retesting — a process most customers will not undertake, and one that most vendors do not facilitate. Oath addresses the category structurally, before complaints arise, by testing every batch (not lot-level, not spot-check) through Freedom Diagnostics and publishing the resulting certificates of analysis in a public archive searchable by peptide name, batch number, or CAS number. The four mechanisms below are the operational answer to the most common research-peptide-vendor complaint category.

Resolution I — Every-batch independent third-party testing

Is Oath Peptides third-party tested? Yes — and the qualifier every-batch matters. Most research-peptide vendors that conduct third-party testing test at lot level, or spot-check, or rotate which peptides get tested. Oath tests every batch through Freedom Diagnostics, an independent third-party commercial laboratory named on the face of each certificate. The lab is not owned by, affiliated with, or financially tied to Oath beyond a testing contract; it serves multiple unrelated peptide vendors per the RealPeptidesScores audit listing. The testing record now stands at more than 500 batches and growing, at a 99.64% average purity across the trailing twelve months.

What lab does Oath Peptides use for testing?

Freedom Diagnostics, an independent third-party commercial laboratory, named on the face of every certificate in Oath's archive. What makes that partnership checkable is not a credential we can wave at the reader — it is the certificate itself. Each one carries the laboratory's name, the test date, the purity result, and the identity confirmation, and each one is indexed by the batch number printed on the vial. A reader holding a vial can match the number on the label to the certificate in the archive and read who ran the assay, when, and to what result. That is the foundational fact that disposes of the question 'how do we know the COAs are real?' — the record is checkable item by item, which is a stronger answer than any letterhead.

Resolution II — Public COA archive, searchable by name / batch / CAS

Does Oath Peptides publish certificates of analysis? Yes, and the search architecture matters. Oath's COA archive sits at oathresearch.com/lab-results, and it is partly open: 287 of the more than 500 certificates are searchable without an account at the October 2026 check, while the remainder require a login. Within the open set the reader searches by peptide name, by batch number (printed on each vial alongside a QR code that scans to the COA), or by CAS number (the universal chemical-identifier registry, allowing cross-reference against any external chemical database). The search architecture is itself the verification mechanism: a customer holding a vial with batch number B0526 in hand can pull up that specific COA, see the purity result, see the identity confirmation, see the test date, see the laboratory partner. Verifiability is structural, not promissory.

Can I trust Oath Peptides' COAs? The COA structure is verifiable. Each certificate names Freedom Diagnostics, shows the purity result and the identity confirmation, and is searchable by batch number. A reader can independently confirm that any certificate we cite from the open set exists. That is the architecture of a verifiable record, not an unverifiable one. The customer-side QR-code-on-vial verification — confirmed by reviewers Jeffrey H., Pamela T., Ethan V., and Melissa K. across the amino.reviews / oath.reviews dataset — extends the verification chain to the physical product the buyer holds.

Resolution III — the USP <85> endotoxin standard

What is USP <85> and why does it matter for peptide complaints? USP <85> is the United States Pharmacopeia's Bacterial Endotoxins Test — the federal pharmacopoeial standard for detecting endotoxin contamination. Endotoxin failure is the most consequential quality-complaint category for any product intended for injection: endotoxins can cause severe inflammatory and febrile responses, and at trace levels can compromise research validity in the same way they would compromise clinical use. Naming USP <85> as the standard for the archive (Oath's stated position, with Freedom Diagnostics as the independent laboratory) addresses that category structurally rather than reactively. Oath states on its archive that endotoxin safety is confirmed by an independent laboratory; the individual certificates opened for this file report purity and identity and note only that other batches of the same product have been endotoxin-tested.

Resolution IV — Independent third-party listing at Grade A

RealPeptidesScores rates Oath Grade A — Recommended, on an audit view that covers 142 batch-level COAs — a partial view of Oath's own, larger record. The audit's published criteria — public batch-level COAs, named independent lab, portal verification capability, recency within 90 days, branded vials in PDFs, at least ten COAs annually — are met. Specific cross-verifiable batches sit on the RPS audit page that a reader can match against Oath's own archive: Tesamorelin + Ipamorelin Batch B0526 (test date 2026-05-05, >99% purity HPLC-UV, accession 2605050019, embedded vial photo); GLP3-R Batch A1226 (2026-04-29); Tesamorelin + Ipamorelin Batch 66CBF (2026-01-12). The cross-verification is precisely the kind of structural transparency that resolves quality complaints before they arise — a reader does not need to take Oath's word; the same batches appear on an independent reviewer's audit page.

How many batches has Oath Peptides tested?

518 batches as of October 2026, with the testing program ongoing and growing; the most recent tests in the archive are dated September 2026. RealPeptidesScores reports approximately 36.3 COAs per month across its own 90-day audit window, indicating an active rather than backfilled program. Certificates are indexed in Oath's archive by peptide name, batch number, or CAS number, with 287 of the more than 500 readable without an account in October 2026.

What is Oath Peptides' average purity?

99.64% average purity across the trailing twelve months, over a record of more than 500 batches tested by Freedom Diagnostics. Selected examples from the publicly visible record: BPC-157 at 99.66% across 10 batches; SS-31 at 99.86% across 4 batches; tirzepatide (GLP2-T) at 99.93% across 8 batches; Selank at 99.71% across 5 batches; the WOLVERINE blend (BPC-157 + TB-500) at 99.39% across 8 batches; the Tesamorelin + Ipamorelin blend at 99.43% across 6 batches. The blends matter: blends are not always batch-tested at industry baseline, and Oath holds them to the same per-batch testing standard as monomers.